THOMAS HSING-TEH WANG, M.D.
Osteopathic Medicine at Shady Grove Rd, Rockville, MD

License number
Maryland D65429
Category
Osteopathic Medicine
Type
Internal Medicine
License number
Maryland D65429
Category
Osteopathic Medicine
Type
Cardiovascular Disease
Address
Address
15225 Shady Grove Rd SUITE 201, Rockville, MD 20850
Phone
(301) 670-3000
(301) 924-0186 (Fax)

Personal information

See more information about THOMAS HSING-TEH WANG at radaris.com
Name
Address
Phone
Thomas Wang
114 Canfield Hill Dr, Gaithersburg, MD 20878
(301) 948-3629
Thomas Wang
11219 White Barn Ct, Gaithersburg, MD 20879
Thomas T Wang, age 68
11816 Beekman Pl, Potomac, MD 20854
(301) 217-0794
Thomas T Wang, age 68
114 Canfield Hill Dr, Gaithersburg, MD 20878
(301) 948-3629
(301) 670-8960
Thomas T Wang
11219 White Barn Ct, Gaithersburg, MD 20879

Professional information

See more information about THOMAS HSING-TEH WANG at trustoria.com
Thomas H Wang Photo 1
Dr. Thomas H Wang, Olney MD - MD (Doctor of Medicine)

Dr. Thomas H Wang, Olney MD - MD (Doctor of Medicine)

Specialties:
Cardiology
Address:
Cardiac Associates PC
18109 Prince Philip Dr SUITE 125, Olney 20832
(301) 634-4800 (Phone)
Cardiac Associates
15225 Shady Grove Rd SUITE 201, Rockville 20850
(301) 670-3000 (Phone)
Procedures:
Cardiac Catheterization (incl. Coronary Angiography), Cardiac Imaging, Cardiac Myocardial Perfusion Imaging, Cardioversion, Elective, Cardioverter-Defibrillator or Pacemaker Insertion, Removal or Repair, Chest CT (incl. Heart and Lungs), Coronary Angioplasty, Atherectomy and Stent, Peripheral Artery Catheterization, Thoracentesis, Tilt Testing or Cardiac Event Monitors
Conditions:
Aneurysm and Dissection of Heart, Angina and Acute Coronary Syndrome, Aortic Aneurysm, Aortic Dissection, Aortic Ectasia, Aortic Valve Disease, Arrhythmias (incl. Atrial Fibrillation), Cardiomegaly, Cardiomyopathy, Carotid Artery Disease, Congenital Heart Disease, Congestive Heart Failure, Coronary Artery Disease (CAD), Endocarditis, Heart Attack (Acute Myocardial Infarction), Hyperlipidemia, Hypertension, Hypertensive Heart and Chronic Kidney Disease, Hypertensive Heart Disease, Hypotension, Mitral Valve Disease, Pericardial Disease, Pulmonary Hypertension, Syncope, Tricuspid Valve Disease
Languages:
English, Spanish
Hospitals:
Cardiac Associates PC
18109 Prince Philip Dr SUITE 125, Olney 20832
Cardiac Associates
15225 Shady Grove Rd SUITE 201, Rockville 20850
MedStar Montgomery Medical Center
18101 Prince Philip Dr, Olney 20832
Washington Adventist Hospital
7600 Carroll Ave, Takoma Park 20912
Laurel Regional Hospital
7300 Van Dusen Rd, Laurel 20707
Suburban Hospital
8600 Old Georgetown Rd, Bethesda 20814
Shady Grove Adventist Hospital
9901 Medical Center Dr, Rockville 20850
Education:
Medical School
Virginia Commonwealth University School Of Medicine
Graduated: 2001


Thomas Hsing-Teh Wang Photo 2
Thomas Hsing-Teh Wang, Rockville MD

Thomas Hsing-Teh Wang, Rockville MD

Specialties:
Internal Medicine, Cardiovascular Disease, Interventional Cardiology, Cardiology
Work:
Cardiac Associates
15225 Shady Grove Rd, Rockville, MD 20850 Cardiac Associates
19735 Germantown Rd, Germantown, MD 20874 Cardiac Associates
18109 Prince Philip Dr, Olney, MD 20832
Education:
University of Virginia (2001)


Thomas Wang Photo 3
Glyceollins Suppress Androgen-Responsive Prostate Cancer

Glyceollins Suppress Androgen-Responsive Prostate Cancer

US Patent:
2013004, Feb 14, 2013
Filed:
Dec 22, 2009
Appl. No.:
13/141572
Inventors:
Thomas E. Cleveland - Mandeville LA, US
Stephen M. Boue - New Orleans LA, US
Matthew E. Burow - Slidell LA, US
Thomas T.Y. Wang - Potomac MD, US
Assignee:
UNITED STATES DEPARTMENT OF AGRICULTURE - Beltsville MD
THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND - New Orleans LA
International Classification:
A61K 31/35, C07D 493/14, A61P 35/00, C12N 5/09
US Classification:
514453, 435375, 549382
Abstract:
The present disclosure demonstrates the molecular effects of glyceollins on human prostate cancer cell LNCaP to further elucidate its potential effects on prostate cancer prevention. The glyceollins inhibited LNCaP cell growth similar to that of the soy isoflavone genistein. The growth inhibitory effects of the glyceollins appeared to be due to an inhibition on G1/S progression and correlated with an up-regulation of cyclin-dependent kinase inhibitor A1 and B1 mRNA and protein levels. By contrast, genistein only up-regulates cyclin-dependent kinase inhibitor A1. In addition, glyceollin treatments led to down-regulated mRNA levels for androgen responsive genes. In contrast to genistein, this effect of glyceollins on androgen responsive genes appeared to be mediated through modulation of an estrogen- but not androgen-mediated pathway. Hence, the glyceollins exerted multiple effects on LNCaP cells that may be considered cancer preventive and the mechanisms of action appeared to be different from other soy-derived phytochemicals.